News articles

News article list

• NICE chronic lung disease treatment decision could benefit 5,200 people

  NICE broadens nintedanib recommendation on chronic lung disease treatment.

• New life-extending treatment for rare forms of advanced gastroesophageal cancer

  Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).

• Targeted treatment for rare form of aggressive lung cancer gets NICE approval

  Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer

• 3 treatments for COVID-19 recommended in draft guidance

  Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.

• Adapted shoes recommended for people with severe osteoarthritis

  People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.

• Further treatment option for triple-negative breast cancer recommended

  NICE has today (8 November 2022) published final draft guidance which recommends pembrolizumab as an option for people with a type of breast cancer called triple-negative breast cancer.